I note also that there have been plenty of Aussie companies that focused on excellent R&D at the expense of commercialisation that are no longer with us.
PolyNovo has escaped that fate and in the years to come will have, no doubt, a broad portfolio of NovoSorb products just because in its early days it focused on bringing in the dollars.
- Forums
- ASX - By Stock
- Medtronic has entered the market for resorbable mesh Ventral Hernia Repair
I note also that there have been plenty of Aussie companies that...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.54 |
Change
0.000(0.00%) |
Mkt cap ! $1.753B |
Open | High | Low | Value | Volume |
$2.55 | $2.56 | $2.50 | $2.498M | 986.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 25659 | $2.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.55 | 274 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 25659 | 2.530 |
1 | 8234 | 2.520 |
3 | 38234 | 2.510 |
5 | 38140 | 2.500 |
2 | 27000 | 2.490 |
Price($) | Vol. | No. |
---|---|---|
2.550 | 274 | 1 |
2.560 | 5000 | 1 |
2.580 | 14318 | 3 |
2.590 | 8659 | 2 |
2.600 | 19657 | 6 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online